speb/financial-data huggingface dataset:
WOA.AX income_statement (annual, 2024-06-30) — +Operating Expense: 9041589.00
WOA.AX income_statement (annual, 2024-06-30) — +Total Revenue: 73130.00
WOA.AX balance_sheet (annual, 2024-06-30) — Accounts Payable: 1133950.00
WOA.AX balance_sheet (annual, 2024-06-30) — Accounts Receivable: 1363111.00
WOA.AX balance_sheet (annual, 2024-06-30) — Accumulated Depreciation: -1601784.00
WOA.AX income_statement (annual, 2024-06-30) — Amortization: 329488.00
WOA.AX income_statement (annual, 2024-06-30) — Amortization Of Intangibles Income Statement: 329488.00
WOA.AX income_statement (annual, 2024-06-30) — Basic Average Shares: 172151541.00
WOA.AX income_statement (annual, 2024-06-30) — Basic EPS: -0.07
WOA.AX cash_flow (annual, 2024-06-30) — Beginning Cash Position: 5871597.00
WOA.AX cash_flow (annual, 2024-06-30) — Capital Expenditure: -582391.00
WOA.AX balance_sheet (annual, 2024-06-30) — Capital Lease Obligations: 537948.00
WOA.AX balance_sheet (annual, 2024-06-30) — Capital Stock: 52225087.00
WOA.AX balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 1985835.00
WOA.AX balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 1985835.00
WOA.AX balance_sheet (annual, 2024-06-30) — Cash Financial: 1985835.00
WOA.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: 10225199.00
WOA.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: -4619891.00
WOA.AX cash_flow (annual, 2024-06-30) — Cash Flowsfromusedin Operating Activities Direct: -9247575.00
WOA.AX cash_flow (annual, 2024-06-30) — Changes In Cash: -3642267.00
WOA.AX cash_flow (annual, 2024-06-30) — Classesof Cash Payments: -21310329.00
WOA.AX cash_flow (annual, 2024-06-30) — Classesof Cash Receiptsfrom Operating Activities: 12001064.00
WOA.AX balance_sheet (annual, 2024-06-30) — Common Stock: 52225087.00
WOA.AX balance_sheet (annual, 2024-06-30) — Common Stock Equity: 5202270.00
WOA.AX cash_flow (annual, 2024-06-30) — Common Stock Issuance: 10207738.00
WOA.AX income_statement (annual, 2024-06-30) — Cost Of Revenue: 1858477.00
WOA.AX balance_sheet (annual, 2024-06-30) — Current Assets: 4236046.00
WOA.AX balance_sheet (annual, 2024-06-30) — Current Capital Lease Obligation: 114754.00
WOA.AX balance_sheet (annual, 2024-06-30) — Current Debt: 500000.00
WOA.AX balance_sheet (annual, 2024-06-30) — Current Debt And Capital Lease Obligation: 614754.00
WOA.AX balance_sheet (annual, 2024-06-30) — Current Liabilities: 5470755.00
WOA.AX balance_sheet (annual, 2024-06-30) — Current Provisions: 205167.00
WOA.AX income_statement (annual, 2024-06-30) — Depreciation Amortization Depletion Income Statement: 731503.00
WOA.AX income_statement (annual, 2024-06-30) — Depreciation And Amortization In Income Statement: 731503.00
WOA.AX income_statement (annual, 2024-06-30) — Depreciation Income Statement: 402015.00
WOA.AX income_statement (annual, 2024-06-30) — Diluted Average Shares: 172151541.00
WOA.AX income_statement (annual, 2024-06-30) — Diluted EPS: -0.07
WOA.AX income_statement (annual, 2024-06-30) — EBIT: -5288439.00
WOA.AX income_statement (annual, 2024-06-30) — EBITDA: -4556936.00
WOA.AX cash_flow (annual, 2024-06-30) — Effect Of Exchange Rate Changes: -243495.00
WOA.AX cash_flow (annual, 2024-06-30) — End Cash Position: 1985835.00
WOA.AX cash_flow (annual, 2024-06-30) — Financing Cash Flow: 10225199.00
WOA.AX balance_sheet (annual, 2024-06-30) — Foreign Currency Translation Adjustments: -210942.00
WOA.AX cash_flow (annual, 2024-06-30) — Free Cash Flow: -9829966.00
WOA.AX balance_sheet (annual, 2024-06-30) — Gains Losses Not Affecting Retained Earnings: 4860735.00
WOA.AX income_statement (annual, 2024-06-30) — General And Administrative Expense: 5969348.00
WOA.AX balance_sheet (annual, 2024-06-30) — Goodwill And Other Intangible Assets: 1210405.00
WOA.AX balance_sheet (annual, 2024-06-30) — Gross PPE: 4836163.00
WOA.AX income_statement (annual, 2024-06-30) — Gross Profit: -1785347.00
WOA.AX income_statement (annual, 2024-06-30) — Impairment Of Capital Assets: 1417757.00
WOA.AX income_statement (annual, 2024-06-30) — Interest Expense: 169872.00
WOA.AX income_statement (annual, 2024-06-30) — Interest Expense Non Operating: 169872.00
WOA.AX income_statement (annual, 2024-06-30) — Interest Income: 61289.00
WOA.AX income_statement (annual, 2024-06-30) — Interest Income Non Operating: 61289.00
WOA.AX cash_flow (annual, 2024-06-30) — Interest Received Direct: 61690.00
WOA.AX balance_sheet (annual, 2024-06-30) — Inventory: 456143.00
WOA.AX balance_sheet (annual, 2024-06-30) — Invested Capital: 5702270.00
WOA.AX cash_flow (annual, 2024-06-30) — Investing Cash Flow: -4619891.00
WOA.AX cash_flow (annual, 2024-06-30) — Issuance Of Capital Stock: 10207738.00
WOA.AX cash_flow (annual, 2024-06-30) — Issuance Of Debt: 795000.00
WOA.AX balance_sheet (annual, 2024-06-30) — Long Term Capital Lease Obligation: 423194.00
WOA.AX balance_sheet (annual, 2024-06-30) — Long Term Debt And Capital Lease Obligation: 423194.00
WOA.AX cash_flow (annual, 2024-06-30) — Long Term Debt Issuance: 795000.00
WOA.AX cash_flow (annual, 2024-06-30) — Long Term Debt Payments: -90526.00
WOA.AX balance_sheet (annual, 2024-06-30) — Long Term Provisions: 28441.00
WOA.AX balance_sheet (annual, 2024-06-30) — Machinery Furniture Equipment: 4215550.00
WOA.AX cash_flow (annual, 2024-06-30) — Net Business Purchase And Sale: -4037500.00
WOA.AX cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: 10207738.00
WOA.AX income_statement (annual, 2024-06-30) — Net Income: -12739214.00
WOA.AX income_statement (annual, 2024-06-30) — Net Income Common Stockholders: -12739214.00
WOA.AX income_statement (annual, 2024-06-30) — Net Income Continuous Operations: -5458311.00
WOA.AX income_statement (annual, 2024-06-30) — Net Income Discontinuous Operations: -7280903.00
WOA.AX income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: -12739214.00
WOA.AX income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: -5458311.00
WOA.AX income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: -12739214.00
WOA.AX income_statement (annual, 2024-06-30) — Net Interest Income: -108583.00
WOA.AX cash_flow (annual, 2024-06-30) — Net Issuance Payments Of Debt: 704474.00
WOA.AX cash_flow (annual, 2024-06-30) — Net Long Term Debt Issuance: 704474.00
WOA.AX income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: -108583.00
WOA.AX cash_flow (annual, 2024-06-30) — Net Other Financing Charges: -1329100.00
WOA.AX balance_sheet (annual, 2024-06-30) — Net PPE: 3234379.00
WOA.AX cash_flow (annual, 2024-06-30) — Net PPE Purchase And Sale: -582391.00
WOA.AX balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 3991865.00
WOA.AX balance_sheet (annual, 2024-06-30) — Non Current Accounts Receivable: 1473446.00
WOA.AX income_statement (annual, 2024-06-30) — Normalized EBITDA: -2939179.00
WOA.AX income_statement (annual, 2024-06-30) — Normalized Income: -3840554.00
WOA.AX income_statement (annual, 2024-06-30) — Operating Income: -10826936.00
WOA.AX income_statement (annual, 2024-06-30) — Operating Revenue: 73130.00
WOA.AX balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 223523419.00
WOA.AX balance_sheet (annual, 2024-06-30) — Other Current Assets: 195383.00
WOA.AX balance_sheet (annual, 2024-06-30) — Other Current Borrowings: 500000.00
WOA.AX balance_sheet (annual, 2024-06-30) — Other Current Liabilities: 2609208.00
WOA.AX balance_sheet (annual, 2024-06-30) — Other Equity Adjustments: 5071677.00
WOA.AX income_statement (annual, 2024-06-30) — Other Gand A: 1936416.00
WOA.AX income_statement (annual, 2024-06-30) — Other Income Expense: 1414037.00
WOA.AX balance_sheet (annual, 2024-06-30) — Other Intangible Assets: 1210405.00
WOA.AX balance_sheet (annual, 2024-06-30) — Other Inventories: 456143.00
WOA.AX balance_sheet (annual, 2024-06-30) — Other Non Current Assets: 169944.00
WOA.AX income_statement (annual, 2024-06-30) — Other Non Operating Income Expenses: 3031794.00
WOA.AX income_statement (annual, 2024-06-30) — Other Operating Expenses: 2122788.00
WOA.AX balance_sheet (annual, 2024-06-30) — Other Payable: 907676.00
WOA.AX balance_sheet (annual, 2024-06-30) — Other Properties: 620613.00
WOA.AX balance_sheet (annual, 2024-06-30) — Other Receivables: 235574.00
WOA.AX income_statement (annual, 2024-06-30) — Other Special Charges: 200000.00
WOA.AX balance_sheet (annual, 2024-06-30) — Payables: 2041626.00
WOA.AX balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 2041626.00
WOA.AX cash_flow (annual, 2024-06-30) — Paymentsto Suppliersfor Goodsand Services: -21310329.00
WOA.AX income_statement (annual, 2024-06-30) — Pretax Income: -5458311.00
WOA.AX cash_flow (annual, 2024-06-30) — Purchase Of Business: 150000.00
WOA.AX cash_flow (annual, 2024-06-30) — Purchase Of PPE: -582391.00
WOA.AX cash_flow (annual, 2024-06-30) — Receiptsfrom Customers: 9216124.00
WOA.AX cash_flow (annual, 2024-06-30) — Receiptsfrom Government Grants: 2784940.00
WOA.AX balance_sheet (annual, 2024-06-30) — Receivables: 1598685.00
WOA.AX income_statement (annual, 2024-06-30) — Reconciled Cost Of Revenue: 1858477.00
WOA.AX income_statement (annual, 2024-06-30) — Reconciled Depreciation: 731503.00
WOA.AX cash_flow (annual, 2024-06-30) — Repayment Of Debt: -90526.00
WOA.AX balance_sheet (annual, 2024-06-30) — Retained Earnings: -51883552.00
WOA.AX income_statement (annual, 2024-06-30) — Salaries And Wages: 4032932.00
WOA.AX cash_flow (annual, 2024-06-30) — Sale Of Business: -4187500.00
WOA.AX income_statement (annual, 2024-06-30) — Selling And Marketing Expense: 217950.00
WOA.AX income_statement (annual, 2024-06-30) — Selling General And Administration: 6187298.00
WOA.AX balance_sheet (annual, 2024-06-30) — Share Issued: 223523419.00
WOA.AX income_statement (annual, 2024-06-30) — Special Income Charges: -1617757.00
WOA.AX balance_sheet (annual, 2024-06-30) — Stockholders Equity: 5202270.00
WOA.AX balance_sheet (annual, 2024-06-30) — Tangible Book Value: 3991865.00
WOA.AX income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: 0.00
WOA.AX income_statement (annual, 2024-06-30) — Tax Provision: 0.00
WOA.AX income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.00
WOA.AX balance_sheet (annual, 2024-06-30) — Total Assets: 10324220.00
WOA.AX balance_sheet (annual, 2024-06-30) — Total Capitalization: 5202270.00
WOA.AX balance_sheet (annual, 2024-06-30) — Total Debt: 1037948.00
WOA.AX balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 5202270.00
WOA.AX balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 5922390.00
WOA.AX balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 6088174.00
WOA.AX balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 451635.00
WOA.AX income_statement (annual, 2024-06-30) — Total Unusual Items: -1617757.00
WOA.AX income_statement (annual, 2024-06-30) — Total Unusual Items Excluding Goodwill: -1617757.00
WOA.AX balance_sheet (annual, 2024-06-30) — Working Capital: -1234709.00
WOA.AX income_statement (annual, 2025-06-30) — Basic Average Shares: 533403008.00
WOA.AX income_statement (annual, 2025-06-30) — Basic EPS: -0.01
WOA.AX income_statement (annual, 2025-06-30) — Diluted Average Shares: 533403008.00
WOA.AX income_statement (annual, 2025-06-30) — Diluted EPS: -0.01
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -21310000000.00
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 16150000000.00
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -1130000000.00
WOCKPHARMA.NS income_statement (annual, 2022-03-31) — Amortization: 190000000.00
WOCKPHARMA.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 120560315.00
WOCKPHARMA.NS income_statement (annual, 2022-03-31) — Basic EPS: -20.24
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 11860000000.00
WOCKPHARMA.NS cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -20000000.00
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 3700000000.00
WOCKPHARMA.NS cash_flow (annual, 2022-03-31) — Change In Other Current Assets: -140000000.00
WOCKPHARMA.NS cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -20000000.00
WOCKPHARMA.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 120965007.00
WOCKPHARMA.NS income_statement (annual, 2022-03-31) — Diluted EPS: -20.24
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 0.00
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 3520000000.00
WOCKPHARMA.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of Business: 0.00
WOCKPHARMA.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 1480000000.00
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 10310000000.00
WOCKPHARMA.NS income_statement (annual, 2022-03-31) — Interest Income: 60000000.00
WOCKPHARMA.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 60000000.00
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 3580000000.00
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 29610000000.00
WOCKPHARMA.NS cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: 0.00
WOCKPHARMA.NS income_statement (annual, 2022-03-31) — Net Income Discontinuous Operations: 0.00
WOCKPHARMA.NS cash_flow (annual, 2022-03-31) — Net Preferred Stock Issuance: 0.00
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 0.00
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 320000000.00
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 1370000000.00
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Other Payable: 1940000000.00
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 620000000.00
WOCKPHARMA.NS income_statement (annual, 2022-03-31) — Other Special Charges: 1830000000.00
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 660000000.00
WOCKPHARMA.NS cash_flow (annual, 2022-03-31) — Preferred Stock Payments: 0.00
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 2900000000.00
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 3680000000.00
WOCKPHARMA.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 310000000.00
WOCKPHARMA.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 310000000.00
WOCKPHARMA.NS cash_flow (annual, 2022-03-31) — Repurchase Of Capital Stock: 0.00
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 360000000.00
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 12760000000.00
WOCKPHARMA.NS cash_flow (annual, 2022-03-31) — Sale Of Business: 0.00
WOCKPHARMA.NS cash_flow (annual, 2022-03-31) — Sale Of Intangibles: 0.00
WOCKPHARMA.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 1800000000.00
WOCKPHARMA.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 3280000000.00
WOCKPHARMA.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 170000000.00
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Tradeand Other Payables Non Current: 1520000000.00
WOCKPHARMA.NS balance_sheet (annual, 2022-03-31) — Work In Process: 490000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — +Operating Expense: 16360000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — +Total Revenue: 26460000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 8670000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 7970000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -22020000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 16180000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -1130000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Amortization: 240000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 240000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 2940000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 640000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 144064321.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Basic EPS: -38.79
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 3700000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 10880000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -2090000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 2970000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 720000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 900000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 900000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 900000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 1410000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 0.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -2050000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 2170000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: 1530000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -2870000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Common Stock: 720000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: 0.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 33540000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 0.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 4260000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 11590000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Assets: 22080000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 710000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Debt: 16630000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 17340000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 34350000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 440000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Depreciation: 2270000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 2510000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 2510000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 2270000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 144064321.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Diluted EPS: -38.79
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -5590000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — EBIT: -3320000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — EBITDA: -810000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 70000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — End Cash Position: 900000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -3150000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 2620000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -560000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 590000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 1100000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Goodwill: 9450000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 21450000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 9100000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 46500000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Gross Profit: 14870000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Interest Expense: 2920000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 2920000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Interest Income: 40000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 40000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -2420000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 20000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Inventory: 6580000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 52410000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -1250000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 0.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 0.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 4090000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 2660000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 2260000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 2240000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 4500000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 3280000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -4060000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 260000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 27670000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 3080000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Minority Interests: 620000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 0.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Net Debt: 17970000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -800000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Net Income: -5590000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -5590000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -6210000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -5590000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -5590000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -6240000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -6210000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Net Intangibles Purchase And Sale: -1670000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Net Interest Income: -2980000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 30000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -780000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -2980000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 30000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Net PPE: 24480000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: 370000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 810000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 12090000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 780000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 6080000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 320000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 260000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 1420000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 1850000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Normalized Income: -2942768000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 1530000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Operating Income: -1490000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Operating Revenue: 26460000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 144088323.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 3090000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 130000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 160000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 12000000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 2950000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 1070000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 780000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 90000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 4740000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Payable: 3090000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Properties: 1030000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 260000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 600000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Other Special Charges: 2530000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Payables: 11980000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 520000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 3090000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Pretax Income: -6240000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 720000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Purchase Of Intangibles: -1670000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -420000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 3420000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 11590000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 2510000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 340000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 340000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -4060000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 340000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Restructuring And Mergern Acquisition: 130000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 7100000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 790000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 1340000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 2440000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Share Issued: 144088323.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 810000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Short Term Debt Payments: -1160000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Special Income Charges: -2660000000.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 10000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 33540000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 12090000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -12768000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Tax Provision: -30000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.00
WOCKPHARMA.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -110000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Total Assets: 76830000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 35780000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Total Debt: 21840000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 36620000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Total Expenses: 27950000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 40210000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 54750000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 5860000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 100000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 220000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -2660000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -2660000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Work In Process: 540000000.00
WOCKPHARMA.NS balance_sheet (annual, 2023-03-31) — Working Capital: -12270000000.00
WOCKPHARMA.NS income_statement (annual, 2023-03-31) — Write Off: 0.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — +Operating Expense: 16230000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — +Total Revenue: 27890000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 7660000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 6180000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -23760000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 20800000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -1580000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Assets Held For Sale Current: 1110000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 650000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 144252058.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Basic EPS: -32.05
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 900000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 10930000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -2160000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 2440000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 770000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 5050000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 5050000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 5050000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 80000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -1930000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Change In Receivables: 1770000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -80000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 4160000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Common Stock: 770000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: 0.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 33590000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 4680000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 4430000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 12190000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Current Assets: 21840000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 740000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Current Debt: 12210000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 12950000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 27910000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 390000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Depreciation: 2230000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 2230000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 2230000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 2230000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 144474519.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Diluted EPS: -32.05
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: -4630000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — EBIT: -1290000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — EBITDA: 940000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: -10000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — End Cash Position: 5050000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 3340000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 2830000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 30000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 520000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 1050000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Goodwill: 9530000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 22940000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 7760000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 46940000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Gross Profit: 15700000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Interest Expense: 2910000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 2910000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Interest Income: 60000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 60000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -1970000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 30000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Inventory: 6400000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 54710000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -1370000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 0.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 4680000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 5490000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 2620000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 1700000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 8910000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 10610000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 4770000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -3680000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 280000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 28010000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 3030000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Minority Interests: 90000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 4680000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Net Debt: 16070000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -20000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Net Income: -4630000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: -4630000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: -4720000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: -4630000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: -4630000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: -4200000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: -4720000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Net Intangibles Purchase And Sale: -1570000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Net Interest Income: -2990000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 0.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 1430000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 1090000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -2990000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: 100000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Net PPE: 23180000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: 70000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 340000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 10650000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 720000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 5790000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 350000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 280000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 1400000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 2390000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Normalized Income: -3615000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 2190000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Operating Income: -530000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Operating Revenue: 27890000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 153400936.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 2680000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 130000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 130000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 13410000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 2560000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 1010000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 720000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 750000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 5130000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Other Payable: 1860000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Other Properties: 950000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 180000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 420000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Other Special Charges: 660000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Payables: 9620000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 410000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 2680000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Pretax Income: -4200000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 680000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Purchase Of Intangibles: -1570000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: 0.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -590000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 3080000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 12190000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 2230000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 360000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 360000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -4060000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 240000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 2400000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 660000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 1250000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 2300000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Share Issued: 153400936.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Short Term Debt Issuance: 720000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Short Term Debt Payments: -380000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Special Income Charges: -1450000000.00
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 10000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 33590000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 10650000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -435000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Tax Provision: 520000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.30
WOCKPHARMA.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -300000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Total Assets: 76490000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 42500000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Total Debt: 23560000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 36620000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Total Expenses: 28420000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 39870000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 54650000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 11960000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 140000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 100000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -1450000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -1450000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 0.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Work In Process: 490000000.00
WOCKPHARMA.NS balance_sheet (annual, 2024-03-31) — Working Capital: -6070000000.00
WOCKPHARMA.NS income_statement (annual, 2024-03-31) — Write Off: 790000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 6770000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 6950000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Assets Held For Sale Current: 1040000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 660000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 1890000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 770000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 1430000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 2580000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 770000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 33950000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 4810000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 20080000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 660000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 9350000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 10010000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 23800000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 490000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 9910000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 24480000000.00
WOCKPHARMA.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 22870000000.00